000			02187nam a2200349Ia 4500
001			CRC0KE11636PDF
003			BD-DhSAU
005			20151012144306.0
006			m|||||o||d||||||||
007			cr||||
008			110310s2011 fluacd sb 001 0 eng d
020			_a9781439836071 (ebook : PDF)
040			_aBD-DhSAU _cBD-DhSAU
090			_aR857.T55 _bD45 2011
092			_a610.28 _bD355
245	0	4	_aThe delivery of regenerative medicines and their impact on healthcare _h[electronic resource] / _cedited by Catherine D. Prescott, Dame Julia Polak.
260			_aBoca Raton : _bCRC Press/Taylor & Francis, _c2011.
300			_axvi, 400 p. : _bill., ports.
504			_aIncludes bibliographical references and index.
505	0		_asection 1. Introduction -- section 2. Finance -- section 3. Business models -- section 4. Intellectual property -- section 5. Regulatory landscape -- section 6. Reimbursement -- section 7. Insurance and risk management.
520			_a"Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It highlights key issues beyond science and clinical translation, such as finance and business models, intellectual property and regulatory landscapes as well as questions of how regenerative medicines will be evaluated for reimbursement. This book will become a pivotal reference to anyone within the healthcare sector interested in understanding and investing in the delivery of regenerative medicines to the benefit of patients"--Provided by publisher.
530			_aAlso available in print edition.
538			_aMode of access: World Wide Web.
650		0	_aTissue engineering _xEconomic aspects.
650		0	_aRegenerative medicine _xEconomic aspects.
650		0	_aMedical care _xEconomic aspects.
655		7	_aElectronic books. _2lcsh
700	1		_aPrescott, C. D. _q(Catherine D.)
700	1		_aPolak, Julia M.
776	1		_z9781439836064
856	4	0	_uhttp://marc.crcnetbase.com/isbn/9781439836071 _qapplication/PDF
999			_c11801 _d11800